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Abstract The purpose of the study was to determine the overall risk of a permanent stoma in patients with complicated
perianal Crohn’s disease, and to identify risk factors predicting stoma carriage. A total of 102 consecutive patients presented
with the first manifestation of complicated perianal Crohn’s disease in our outpatient department between 1992 and 1995.
Ninety-seven patients (95%) could be followed up at a median of 16 years after first diagnosis of Crohn’s disease. Patients
were sent a standardized questionnaire and patient charts were reviewed with respect to the recurrence of perianal abscesses
or fistulas and surgical treatment, including fecal diversion. Factors predictive of permanent stoma carriage were determined
by univariate and multivariate analysis. Thirty of 97 patients (31%) with complicated perianal Crohn’s disease eventually
required a permanent stoma. The median time from first diagnosis of Crohn’s disease to permanent fecal diversion was
8.5 years (range 0–23 years). Temporary fecal diversion became necessary in 51 of 97 patients (53%), but could be
successfully removed in 24 of 51 patients (47%). Increased rates of permanent fecal diversion were observed in 54% of
patients with complex perianal fistulas and in 54% of patients with rectovaginal fistulas, as well as in patients that had
undergone subtotal colon resection (60%), left-sided colon resection (83%), or rectal resection (92%). An increased risk for
permanent stoma carriage was identified by multivariate analysis for complex perianal fistulas (odds ratio [OR] 5; 95%
confidence interval [CI] 2–18), temporary fecal diversion (OR 8; 95% CI 2–35), fecal incontinence (OR 21, 95% CI 3–
165), or rectal resection (OR 30; 95% CI 3–179). Local drainage, setons, and temporary stoma for deep and complicated
fistulas in Crohn’s disease, followed by a rectal advancement flap, may result in closing of the stoma in 47% of the time.
The risk of permanent fecal diversion was substantial in patients with complicated perianal Crohn’s disease, with patients
requiring a colorectal resection or suffering from fecal incontinence carrying a particularly high risk for permanent fecal
diversion. In contrast, patients with perianal Crohn’s disease who required surgery for small bowel disease or a segmental
colon resection carried no risk of a permanent stoma.
Keywords Fecaldiversion.Crohn’sdisease.
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Introduction
Crohn’s disease was initially described as a nonspecific
inflammatory bowel disease, affecting mainly the terminal
ileum and characterized by a subacute or chronic necrotiz-
ing and cicatrizing inflammation.
1 Eventually, gastrointes-
tinal Crohn’s disease became recognized as a full-thickness
disease of the gastrointestinal wall that may affect the entire
gastrointestinal tract, including the perianal region.
2–6
Perianal lesions are common in patients with Crohn’s
disease.
7–13 Clinical manifestations vary from asymptomatic
skin tags to severe, debilitating perianal destruction and sepsis.
Asymptomatic perianal lesions require no treatment, but
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surgical treatment. Surgical management needs to be conser-
vative and should focus on the drainage of septic sites,
preserving sphincter function and palliating symptoms.
10–13
Medical management has had some success in improving
symptoms, but as yet, it has not been able to eliminate most
perianal complaints permanently.
14,15
Fecal diversion was successfully used to achieve
remission in colonic Crohn’s disease. Moreover, it was
utilized to allow severe perianal disease to settle, thereby
avoiding proctectomy.
16–19 However, restoring the intesti-
nal passage carries the risk of recurrent perianal disease
activity, possibly resulting in a decreased quality of life
compared to the situation with fecal diversion.
We investigated the overall risk of a permanent stoma in
patients with severe perianal Crohn’s disease and tried to
identify risk factors predicting permanent stoma carriage.
Methods
Patients
A total of 102 consecutive patients with Crohn’s disease
presented with the first manifestation of a perianal fistula or
a perianal abscess in our outpatient department between
1992 and 1995. Patients were investigated in Trendelen-
burg’s position by perianal inspection, proctoscopy, recto-
scopy, and rigid sigmoidoscopy. Endoanal ultrasound was
performed in case of suspected perianal abscess formation,
and MRI was conducted of the pelvic floor in case of
complicated fistulizing disease or intrapelvic abscess
formation. All patients were documented prospectively.
Follow-up data of 97 patients (95%) were available by a
standardized questionnaire mailed to the patients and by a
standardized chart review. There were 50 female and 47
male patients (ratio 1.06:1) with a median age of 23 years
(range 8–51 years). Patients were evaluated with respect to
the recurrence of perianal abscesses, fistulas, or surgical
treatment of Crohn’s disease over the years. The median
interval between the first diagnosis of Crohn’s disease and
last follow-up was 16 years (range 8–37 years). Four
patients had isolated small intestinal disease, 11 patients
had isolated colonic disease, and 82 patients had small
intestinal and colonic disease.
The abscess location was categorized as subcutaneous,
intersphincteric, deep perianal, ischiorectal, and above the
pelvic floor. Abscess formations were categorized into
simple (subcutaneous, intersphincteric, deep perianal, and
ischiorectal, circular extension less than 90°, pelvic floor
not involved) and complicated (circular extension more
than 90° [horse shoe abscess] or pelvic floor involved).
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01 0 2 0 3 0
R
e
l
a
t
i
v
e
 
p
r
o
p
o
r
t
i
o
n
 
o
f
 
p
a
t
i
e
n
t
s
 
w
i
t
h
o
u
t
 
p
e
r
m
a
n
e
n
t
 
s
t
o
m
a
0.0
0.2
0.4
0.6
0.8
1.0
Patients at risk  
  97 89 77 48    21   6  5  2
Figure 1 Relative proportion of
patients without permanent sto-
ma in complicated perianal
Crohn’s disease (n=97) during
follow-up.
530 J Gastrointest Surg (2007) 11:529–537Fistulas were classified according to Parks et al.
20 into
subcutaneous, intersphincteric, extrasphincteric, trans-
sphincteric, rectovaginal, and suprasphincteric, as described
previously.
21 We divided fistulas into simple fistulas (no
more than two perianal openings) and complex fistulas
(rectovaginal, three or more perianal openings).
A variety of factors, such as sex of the patient, perianal
fistula, rectovaginal fistula, abscess formation, anal stricture,
fecal incontinence, or abdominal surgery were evaluated
with regard to their predictive character for permanent stoma
carriage by univariate and multivariate analysis.
Statistical Analysis
Kaplan–Meier analysis using a log-rank test was used for
comparing risk rates over time. Factors that might influence
permanent fecal diversion were analyzed using the chi-square
test. Fisher’s exact test was used for univariate analysis and
multiple logistic regression and Wald’s test for multivariate
analysis. Subgroup analysis was performed for rectovaginal
fistulas, as present in female patients only. Data are given as
numbers of cases and percentages or median and interquartile
ranges. A P<0.05 was considered as significant.
Results
Overall Risk of Permanent Fecal Diversion
Thirty of 97 patients (31%) with perianal Crohn’s disease
eventually required a permanent stoma. Nineteen patients
were female and 11 male (ratio 1.73:1). The median time
from first diagnosis of Crohn’s disease to permanent fecal
diversion was 8.5 years (range 0–23 years; Fig. 1).
Increased rates of permanent fecal diversion were observed
in 53% of patients with previous temporary fecal diversion,
in 54% of patients with complex perianal fistulas, in 54% of
female patients with rectovaginal fistulas, and in 83% of
patients with fecal incontinence (Table 1). Patients who
required subtotal colon resection (60%), left-sided colon
resection (83%), or rectal resection (93%) needed a
permanent stoma at high rates (Table 2).
Abscess Formation
Seventy-five of 97 patients (77%) had at least one perianal
abscess at first presentation or during follow-up. Surgical
therapy for abscesses consisted of seton drainage, mush-
room catheter drainage, or incision and drainage, as
described previously.
21 A permanent fecal diversion be-
cause of recurrent abscess formations, always in combina-
tion with fistula problems and perianal sepsis, became
necessary in 21 of 75 cases (28%). Simple abscess
formations occurred in 33 patients, and 7 of those patients
Table 1 Patients with First Manifestation of Complicated Perianal Crohn’s
Disease (n=97) and the Rate of Fecal Diversion During Follow-up
Patients Temporary
Stoma
Permanent
Stoma
Overall 97 51 (53%) 30 (31%)
Abscess
formation
75 32 (43%) 21 (28%)
Simple abscess
formation
33 (44%) 13 (39%) 7 (21%)
Complex abscess
formation
42 (56%) 23 (55%) 15 (36%)
Fistulas 88 51 (58%) 26 (30%)
Simple perianal
fistulas
42 (48%) 17 (40%) 8 (19%)
Complex perianal
fistulas
46 (52%) 34 (74%) 23 (50%)
Rectovaginal
fistulas
26 (54% of
♀)
18 (69% of
26)
14 (54% of
26)
Overlap between abscess formation and presence of fistulas exists, and
abscesses led to fecal diversion in combination with fistulas only.
Table 2 Abdominal Procedures and the Rate of Fecal Diversion
During Follow-up in Patients with Complicated Perianal Crohn’s
Disease (n=97)
Patient
Number
Permanent Stoma
(% of Patients)
Small Bowel Procedures
Stricturplasty 7 0
Small bowel resection
because
of stenosis
23 0
Small bowel resection
because
of enteroenteric fistula
70
Anastomosis resection
because of inflammatory
stenosis
30 0
Stoma revision 4 0
Large bowel procedures
Segmental colon
resection
14 0
Right-sided colon
resection
20 4 (20)
Ileocecal
resection
68 24 (35)
Subtotal colon
resection
35 21 (60)
Left-sided colon resection 6 5 (83)
Rectal resection 13 12 (92)
Patients that required small bowel resections carried no risk of fecal
diversion, whereas patients with colon resections carried an increased
risk of fecal diversion.
J Gastrointest Surg (2007) 11:529–537 531(21%) required permanent fecal diversion (Fig. 2). Com-
plex abscess formations were present in 42 patients, with
permanent fecal diversion being necessary in 14 cases
(33%; Table 1).
Perianal and Rectovaginal Fistulas
Perianal fistulas affected 88 of 97 patients (91%), including
26 female patients with rectovaginal fistulas. Symptomatic
fistulas with abscess formation were treated by simple
drainage procedures and provided with a seton. Azathio-
prine therapy was tried if purulent secretion persisted.
Infliximab was rarely used in recent years at the discretion
of the referring gastroenterologist. Overall, permanent fecal
diversion became necessary in 26 of 88 patients (30%).
Forty-two patients (48%) had simple fistulas, whereas 46
patients (52%) had complex fistulas. Of these, permanent
fecal diversion was documented in 14 patients (54%),
whereas simple fistulas eventually required a permanent
stoma in only 8 cases (16%). Twenty-six of 48 female
patients had rectovaginal fistulas, of which 14 (54%)
eventually required permanent fecal diversion (Table 1).
Thirty-four of 97 patients (35%) developed anal strictures,
whereas fecal incontinence was documented in 12 patients
(12%) during the follow-up. In 14 of 34 patients (41%) with
anal stricture, a permanent fecal diversion became necessary,
Patients at risk  
A  42         42            36           21               9               3             2               2
B  46         38            34           23               10             3             2               0
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Figure 2 Relative proportion of
patients without permanent sto-
ma in complicated perianal
Crohn’s disease with simple (n=
42) and complex (n=46) fistulas
during follow-up. The presence
of a complex fistula significant-
ly increased the risk of perma-
nent fecal diversion (P<0.001).
Table 3 Abdominal Procedures per Patient and Percentage of Patients
with Abdominal Surgery
Abdominal
Procedures
Median (25–75%) Patients with
Abdominal
Surgery (%)
P Value
Permanent fecal
diversion
3( 2 –4) 100 P<0.05
Without permanent
fecal diversion
1( 1 –3)
Temporary fecal
diversion
3( 2 –4.25) 80 P<0.05
Without temporary
fecal diversion
1( 0 –2.5)
Anal stricture 2 (1–4) 60 n.s.
Without anal
stricture
2( 1 –3)
Incontinence 2 (2–4.5) 10 n.s.
Without
incontinence
2( 1 –3)
Patients with Crohn’s disease and complicated perianal fistulas who
required temporary or permanent stoma had more abdominal
procedures than patients who did not need a stoma, whereas patients
with anal stricture or fecal incontinence had no increased abdominal
procedure rate (the number of abdominal procedures per patient is
given as median with interquartile ranges). Abdominal surgery and
fecal diversion correlated on univariate analysis (P<0.05).
532 J Gastrointest Surg (2007) 11:529–537whereas 10 of 12 patients (83%) suffering from fecal
incontinence required a permanent stoma.
Abdominal Surgery
Eighty-three of 97 patients with perianal Crohn’sd i s e a s e
(86%) underwent abdominal surgery at least once during
follow-up because of Crohn’s disease activity, with a total of
227 abdominal procedures being performed. In 68 of 227
operations (29%), intestinal stenosis required surgery. Seg-
mental colon resection was performed 108 times (46%),
whereas subtotal colectomy for fulminant colitis was per-
formed 35 times (15%). One patient required surgery because
of a fistula carcinoma. Patients with complicated perianal
Crohn’s disease who required a small bowel resection carried
no risk of permanent fecal diversion, whereas the majority of
patients with left-sided colon resection, subtotal colon resec-
tion, or rectal resection needed permanent fecal diversion
(Table 2). Patients that needed abdominal surgery repeatedly
carried an increased risk for a permanent stoma (permanent
stoma rate: three or more abdominal operations, n=20, 50%;
less than two abdominal operations, n=20, 15%; P<0.043).
Patients with permanent fecal diversion had undergone
previous abdominal surgery three times as often as those
patients without (P<0.05; Table 3). Eventually, 17 patients
(18%) needed proctectomy, of which 13 were female patients
with rectovaginal fistulas. In 14 patients with a permanent
stoma, a rectal stump remained in place and was controlled at
yearly intervals. Patients with complicated perianal Crohn’s
disease and large bowel resection carried a significantly
increased risk of permanent fecal diversion compared to
patients with complicated perianal Crohn’s disease and small
bowel resection (48 vs 0%, P<0.001) (Fig. 3).
Temporary Fecal Diversion
Temporary fecal diversion, done mostly by loop ileostomy,
became necessary in 51 of 97 patients (53%). Increased rates
of temporary fecal diversion were observed in 55% of patients
with complex abscess formations, including those with severe
perianal sepsis, in 77% of patients with complex perianal
fistulas, and in 69% of female patients with rectovaginal
fistulas. In 24 of 51 patients (47%) the temporary stoma could
be removed after perianal disease had subsided. Fistulas were
closedinthesepatientsbyrectaladvancementflaps,
23 whereas
cutting setons, fistulectomy, or infliximab infusions were not
employed in these patients.
Risk Factors Predictive of a Permanent Fecal Diversion
Univariate Analysis
Complex perianal fistulas (P<0.04), fecal incontinence (P<
0.001), and rectovaginal fistulas in female patients (P<0.001)
Figure 3 Treatment algorithm for patients with complicated perianal
Crohn’s disease.
Table 4 Risk Factors for Permanent Fecal Diversion by Univariate
and Multivariate Analysis in Patients with Complicated Perianal
Crohn’s Disease
Risk Factors Univariate Analysis Multivariate Analysis
Permanent Fecal
Diversion (%)
P
Value
OR 95%
CI
P
Value
Rectal
resection
92 P<0.001 30 5–179 P<0.002
Fecal
incontinence
83 P<0.001 21 3–165 P<0.02
Subtotal
colectomy
60 P<0.001
Rectovaginal
fistulas
54 P<0.001
Temporary
fecal
diversion
51 p=0.001 8 2–35 P<0.02
Complex
perianal
fistulas
54 P<0.04 5 2–18 P<0.03
J Gastrointest Surg (2007) 11:529–537 533carried an increased risk for a permanent stoma. Patients
with high rates of abdominal surgery had a significantly
increased risk for fecal diversion, whereas the frequency of
abdominal surgery was not influenced by the presence of
anal stricture or fecal incontinence (Table 3). The need for
subtotal colon resection (P<0.001), rectal resection (P<
0.001), or temporary fecal diversion (P=0.001) also resulted
in an increased risk of permanent fecal diversion. A variety of
factors did not increase the risk of a permanent stoma, such as
sex of the patient, anal stenosis, perianal abscesses, and
abdominal surgery, excluding subtotal colon and rectal
resection (Table 4).
Multivariate Analysis
According to multivariate analysis, complex perianal
fistulas (P<0.03), fecal incontinence (P<0.02), temporary
fecal diversion (P<0.02), or rectal resection (P<0.002) still
carried a significantly increased risk for permanent fecal
diversion (Table 4).
Discussion
Perianal disease is a feature of Crohn’s disease that afflicts
approximately one third of patients, but prevalence rates
vary between 8 and 90%.
19 Patients with colonic involve-
ment will have perianal disease in more than 50% of cases,
whereas patients with small bowel disease are affected in
less than 20%.
24 Perianal Crohn’s disease can present as
minor lesions, such as skin tags, skin excoriations, and
fissures, which rarely need surgical treatment. In contrast,
perianal fistulas often result in abscesses or perianal sepsis,
requiring urgent surgery, and fistulas and abscesses are
considered as suppurative complications of perianal
Crohn’s disease.
25 We conducted surgery as conservatively
as possible because sphincter function should be preserved
as much as possible.
19,22,23 Throughout the study period,
77% of patients developed abscess formations, which is
considerably more than the 48% rate reported previously
with a shorter mean follow-up of 32 months.
22
The incidence of perianal fistulas in Crohn’s disease is
somewhat lower, affecting 10–34% of patients.
26 Healing
rates of 60–70% in patients with Crohn’s disease and
perianal fistulas were reported in earlier series.
21,26–28
However, these series contained a large proportion of
simple fistulas, whereas most of our patients had complex
transsphincteric or rectovaginal fistulas and fistulas that did
not heal through conservative treatment. Perianal fistulas
that resulted in abscess formation were drained surgically,
and in case of massive purulent secretion or perianal sepsis,
oral antibiotics were used additionally. Setons were put into
place to prevent recurrent abscess formation, a treatment
that is well known as a possible means for controlling
perianal sepsis and preventing recurrent abscess forma-
tion.
19,21–23,29 We did not use cutting setons nor fistulot-
omy for transsphincteric fistulas, as fecal incontinence may
succeed.
19,22,23 Infliximab was successfully shown to
reduce fistula secretion, and outer fistula openings may
heal.
30 However, fistula tracks persist with varying degrees
of residual inflammation, which may cause recurrent
fistulas and perianal abscesses.
31
Rectal advancement flaps can be used to close the inner
opening of transsphincteric or rectovaginal fistulas when
perianal disease has abated and the rectal mucosa is not
inflamed. However, fistulas eventually recurred in about
one third of patients after a mean follow-up of 19 months,
and some patients developed new fistulas.
23 Hyman
32
reported an initial 79% healing rate in a series of 14
patients with Crohn’s disease and perianal fistulas, but
observed longer term success in only 50% of patients. Our
current approach is to use rectal advancement flaps for
transsphincteric fistulas while delaying surgery if there is an
acute flare of Crohn’s disease, in particular, if proctitis is
present.
23,33 Perianal fistulas in Crohn’s disease closed by a
rectal advancement flap have a recurrence rate of 50–60%,
but can be attempted repeatedly.
23,34 If a second rectal
advancement flap fails, the failure rate increases up to
75%,
34 and a temporary stoma is suggested to the patient
before a third attempt is made. By this approach, we were
able to heal perianal fistulas in 24 out of 51 patients (47%)
who required a temporary stoma. In a previous study,
diversion was the most powerful factor influencing healing
according to multiple regression analysis.
23 The chances of
a symptomatic fistula recurrence were increased without a
stoma (52% vs 14%, 21), and patients with Crohn’s colitis
carried an increased risk of fistula recurrence.
23
A particular problem is rectovaginal fistulas, which
almost always open at the dentate line.
19 They occur in
3–10% of patients with Crohn’s disease.
19 In our series,
54% of female patients had rectovaginal fistulas, indicating
that a large patient proportion had complex perianal
fistulas; referral bias might have contributed to this high
proportion of rectovaginal fistulas, as our outpatient clinic
for Crohn’s disease is well known regionally. Rectovaginal
fistulas carry a poor prognosis,
18 and a 70% recurrence rate
was observed 24 months after a rectal advancement flap
was performed.
23 In the experience of Keighley et al.
35,1 1
of 13 patients with rectovaginal fistulas required proctec-
tomy with a permanent stoma. In our series, 8 out of 26
rectovaginal fistulas healed by a rectal advancement flap.
Eighteen patients required a temporary stoma, of which
four could be removed after a rectal advancement flap was
tried again successfully (overall healing rate 12 of 26,
46%), resulting in a permanent stoma rate of 14 of 26
patients (54%). Healing rates of rectovaginal fistulas
534 J Gastrointest Surg (2007) 11:529–537associated with Crohn’s disease vary widely, and low
patient numbers are usually reported.
18 In the Cleveland
clinic, 16 of 37 rectovaginal fistulas (43%) healed using an
endorectal advancement flap, but patients not having
Crohn’s disease were included in the study.
36 In low
anovaginal fistulas, higher healing rates of up to 68% were
reported in patients with Crohn’s disease.
37 Recurrent
rectovaginal fistulas were shown to heal after repeated
rectal advancement flap procedures were conducted at
about the same rate even in Crohn’s disease, but surgery
should be delayed for at least 3 months after a previous
repair,
38 which is standard policy at our clinic. It is
interesting to note that Halverson et al.
38 reported that the
presence of a diverting stoma significantly increased the
fistula recurrence rate (67 vs 50%).
After years of perianal or transvaginal pus secretion and
recurrent abscess formations, patients are often tired of the
suffering involved. Antibiotics, azathioprine, or 6-mercap-
topurine may be used successfully in suppurative perianal
Crohn’s disease.
15,18,38,39 In our department, this is rou-
tinely tried if perianal disease does not settle after surgical
drainage is provided. However, azathioprine or 6-mercap-
topurine are not tolerated by all patients and may also fail to
relieve perianal Crohn’s disease. In these cases, fecal
diversion can be offered as a relatively minor procedure
with low morbidity,
18 and might be performed laparoscopi-
cally in selected cases.
40 However, overall healing rates of
perianal disease are only around 40%, with 87% of those
being diverted eventually retaining their stoma.
18 We
diverted 51 patients, of which 27 retained there stoma
(53%), which compares favorably, but indicates a consid-
erable risk for a permanent stoma if diversion is tried, and
being a significant risk factor according to multivariate
analysis in our series.
Perianal disease in combination with fecal incontinence
might necessitate fecal diversion as well. Factors that may
contribute to fecal incontinence in patients with Crohn’s
disease are reduced stool consistency, sphincter injuries
after abscess incisions, and keyhole deformities after laying
open perianal fistulas. The latter was reported to result in
fecal incontinence in 5 of 27 patients with perianal fistulas
in Crohn’s disease,
41 which is why we did not use this
technique or cutting setons in transsphincteric fistulas. We
always incise perianal abscesses along a circular perianal
line, meticulously preserving sphincter integrity. Neverthe-
less, fecal incontinence became prevalent in 12% of our
patients during follow-up and was a significant predictor of
permanent fecal diversion by multivariate analysis. Rectal
advancement flap procedures may influence continence,
22
and a 9% rate of worsened continence was reported
thereafter.
33 In particular, the risk of fecal incontinence was
increased after flap repairs in patients with previous surgical
fistula repairs,
33 but only 2 out of 12 patients with fecal
incontinence had a previous rectal advancement flap repair
in our study. A high rate of abdominal procedures was
associated with an increased risk for a temporary or a
permanent stoma, possibly reflecting high intestinal disease
activity of Crohn’s disease in these patients. All 30 patients
that ended with a permanent stoma had frequently undergone
abdominal procedures (median of three procedures).
Because of the suffering involved and unsuccessful
previous attempts to heal perianal fistulas, about half of
our patients eventually opted for temporary ileostomy,
being brought into contact with a stoma nurse and stoma
carriers with Crohn’s disease before, and 31% of all
patients remained with a permanent stoma. In general, the
need for a stoma was reduced during recent decades in
Crohn’s disease,
43 but the overall long-term risk for a stoma
in patients with Crohn’s disease who require abdominal
surgery was reported between 30 and 40%.
44,45 Fecal
diversion remains an option to subside perianal disease
activity, with an early response rate of about 70–80%.
46–48
Unfortunately, 75% of those patients eventually experi-
enced a relapse, and the restoration of intestinal continuity
was achieved in 10% only.
48 In 130 patients with surgically
treated perianal Crohn’s disease, a permanent stoma
became necessary in 24%, and this rate increased to 53%
in patients with Crohn’s colitis.
45 In this light, considering
that all of our patients had complicated perianal disease and
almost all (93 of 97 patients, 96%) had colonic involve-
ment, we judge a 31% permanent stoma rate as a success in
a subset of patients carrying a particularly high risk for a
stoma. Local drainage, setons, and, if not successful, a
temporary stoma after a rectal advancement flap, resulted in
closure of the stoma in 47% of the time, which is an
improvement compared to previous studies where restora-
tion of intestinal continuity was reported in only 10–40%
of patients, with most studies providing the lower end
percentages.
44,46–48 If perianal Crohn’s disease was the
indication for creating a stoma, stoma closure was
successful in 2 out of 15 patients only (13%).
47
Eventually, proctectomy became necessary in 18% of
patients, which is in the range others have reported.
24,44,49,50
However, if the presence of colonic disease was considered
separately, seven out of eight patients with complicated
perianal Crohn’s disease needed proctectomy, again indicat-
ing that an 18% proctectomy rate in our high-risk population
is rather low. All of our patients who needed proctectomy
had colonic disease, and 13 of 17 had a rectovaginal fistula.
In a recent study investigating the quality of life in
patients with Crohn’s proctocolitis, patients in remission had
a health-related quality of life similar to controls. Patients
with active disease had a reduced quality of life, and only the
symptom index negatively predicted a reduced quality of
life, whereas neither previous colonic surgery nor the
presence of a stoma did.
51 Accordingly, carrying a stoma
J Gastrointest Surg (2007) 11:529–537 535does not necessarily mean a reduced quality of life, although
a slight reduction in two out of eight domains (physical and
emotional role) was detected.
51 However, in patients with
perianal disease, the cumulative abscess rate during 3 years
of follow-up and the symptomatic fistula recurrence rate with
a mean follow-up of 22 months were both greatly reduced
with a stoma (76 vs 13% and 52 vs 14%), indicating reduced
suffering and need for surgery.
21,22
In summary, patients with complicated perianal Crohn’s
disease, colonic involvement, and a high rate of abdominal
procedures carried a significant risk for a permanent stoma.
However,iftheriskfactorsidentifiedweretakenintoaccount,
the rate of patients eventually requiring a permanent stoma
seemed low and showed a decrease compared to previous
studies, indicating that multiple treatment episodes and
complex surgery, including temporary fecal diversion, might
eventually heal at least some patients in this high-risk
population, as was also observed by others.
50
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